Latest Form 4 insider transactions

Philip Andrew Smith, Chief Executive Officer and a Director of StoneX Group Inc., sold 56,250 shares of common stock on September 28, 2026 for $65.69 per share.

David E. Lazar, Chief Executive Officer and a Director of Aterian, Inc., sold 2,456,100 shares of common stock on September 24, 2026.

Han Kyung Park, SVP & GM of FPD Ops of Photronics Inc, sold 9,500 shares of common stock on September 25, 2026 for $30.37 per share.

Nazar M. Khan, Chief Technology Officer and a Director of Terawulf Inc., reported multiple transactions in common stock on September 29, 2026.

Daniel Karlin, Chief Medical Officer and a Director of Mind Medicine (MindMed) Inc., sold 10,853 shares of common stock on September 25, 2026 for $36.57 per share.

Robert Barrow, Chief Executive Officer and a Director of Mind Medicine (MindMed) Inc., sold 31,550 shares of common stock on September 25, 2026 for $36.57 per share.

Michael Feld, EVP, Chief Revenue Officer of Becton Dickinson & Co, sold 76 shares of common stock on September 28, 2026 for $183.70 per share.

Matthew T. Wiley, Chief Commercial Officer of Mind Medicine (MindMed) Inc., sold 3,097 shares of common stock on September 25, 2026 for $36.57 per share.

Mark Sullivan, Chief Legal Officer of Mind Medicine (MindMed) Inc., sold 14,051 shares of common stock on September 25, 2026 for $36.57 per share.

David Natan, a Director of Aterian, Inc., received 301,205 shares of common stock on September 25, 2026.

Brandi Roberts, Chief Financial Officer of Mind Medicine (MindMed) Inc., sold 3,377 shares of common stock on September 25, 2026 for $36.57 per share.

Michael James Carlson, President, Managed Services of Stem, Inc., sold 146 shares of common stock on September 26, 2026 for $4.67 per share.

Cory Vieira, Chief Accounting Officer of Pagaya Technologies Ltd., sold 2,170 shares of common stock on September 25, 2026 for $17.04 per share.

William Kurtz, a Director of Aterian, Inc., received 150,602 shares of common stock on September 25, 2026.

Ryusuke Utsumi, a Director of Cellebrite DI Ltd., received 15,190 shares of common stock on September 17, 2026.

John Kent Walker, President, Global Affairs, CLO of Alphabet Inc., reported multiple transactions in common stock on September 25, 2026.

Marsida Saraci, VP, Chief Accounting Officer of Alphabet Inc., reported multiple transactions in common stock on September 25, 2026.

Ruth Porat, President and CIO of Alphabet Inc., reported multiple transactions in common stock on September 25, 2026.

Anat Ashkenazi, SVP, Chief Financial Officer of Alphabet Inc., reported multiple transactions in common stock on September 25, 2026.

Sundar Pichai, Chief Executive Officer and a Director of Alphabet Inc., reported multiple transactions in common stock on September 25, 2026.

Philipp Schindler, SVP, Chief Business Officer of Alphabet Inc., reported multiple transactions in common stock on September 25, 2026.

Yonatan Domnitz, a Director of Cellebrite DI Ltd., received 15,190 shares of common stock on September 17, 2026.

Joseph Cumello, EVP & General Mgr. of Ciena Corp, sold 1,586 shares of common stock on September 25, 2026 for $358.52 per share.

David S Marriott, a Director of Marriott International Inc /Md/, sold 3,500 shares of common stock on September 25, 2026 for $352.09 per share.

Deborah Marriott Harrison, a Director of Marriott International Inc /Md/, sold 3,500 shares of common stock on September 25, 2026 for $352.09 per share.

J W Marriott Jr, a 10% owner of Marriott International Inc /Md/, sold 3,500 shares of common stock on September 25, 2026 for $352.09 per share.

Victor Perlroth, Chairman and CEO, a Director and 10% owner of Kodiak Sciences Inc., reported multiple transactions in common stock on September 25, 2026.

Elena Marquez, Chief Financial Officer of Anterix Inc., reported a transaction in 1,325 shares of common stock on September 29, 2026.

Dominic Piscitelli, Chief Financial Officer of Oric Pharmaceuticals, Inc., sold 13,400 shares of common stock on September 28, 2026 for $13.53 per share.

Jayshree Ullal, CEO and Chairperson and a Director of Arista Networks, Inc., sold 62,622 shares of common stock on September 25, 2026 for $211.40 per share.